med Sample Clauses

med. Project hereby represents and warrants for itself, and to the extent applicable, with respect to Vendor, as follows:
med. 105.1 MED. 10 Follow-up Site Initiation Visit Letter 105.1 MED. 11 Financial Disclosure Form 105.1 MED. 12 Subject pre-screening Log 105.1 MED. 13 Site Initiation Visit Agenda 2 2 2 2 04 Mar 11 04 Mar 11 04 Mar 11 22 Jan 13 105.1 MED. 14 List of Site Initiation Visit Activities 1 04 Mar 11 105.1 MED. 15 Consent to Processing Personal Data 1 02 Jun 11 105.1 MED. 16 Instruction on How to Manage Consent for Personal Data in Clinical Operation Department 1 27 Aug 12 106.1 MED. Monitoring Visit 2 18 Apr 11 Associated Forms And Templates: 106.1 MED. 01 Confirmation Monitoring Visit Letter 2 18 Apr 11 106.1 MED. 02 Monitoring Visit Report 3 18 Apr 11 106.1 MED. 03 Contact Report 2 18 Apr 11 106.1 MED. 04 Subject Visit Status 2 18 Apr 11 106.1 MED. 05 Note to File 3 18 Apr 11 106.1 MED. 06 Follow-up Monitoring Visit Letter 2 18 Apr 11 106.1 MED. 07 Monitoring Visit and Reporting Plan 2 18 Apr 11 106.1 MED. 08 Data Clarification Form 106.1 MED. 09 Site Personal Training Log 106.1 MED. 10 Confidentiality Violation Log 1 1 1 18 Jul 11 26 Jun 12 26 Jun 12 106.2 MED. Taking Over The Study 3 31 May 13 Associated Forms And Templates: 106.2 MED. 01 CRA Site Take-Over Checklist 5 31 May 13 106.2 MED. 02 CTA Take-Over Checklist 2 31 May 13 106.3 MED. Co-Monitoring Visit 2 25 Jul 11 106.3 MED. 02 Co-monitoring Visit Report: Quality Control Assessment 2 25 Jul 11 106.4 MED. Reporting Protocol Deviations 2 10Aug10 Associated Forms And Templates: 106.4 MED. 01 Protocol deviation report 106.4 MED. 02 Protocol Deviation Cumulative List 2 1 10Aug10 10Aug10 VBL Confidential Information Page 1 of 64 Version 2.2 02 DEC 2013 Portions of this exhibit have been omitted and filed separately with the SEC pursuant to a confidential treatment request and are indicated by [***].
med. Insurance in Clinical Trial Associated Forms And Templates: 114.1 MED. 01 Questionnaire for Insurance Purposes 3 3 15 Apr 13 15 Apr 13 116.1 MED. Clinical Study Report 3 28 Jun 13 Associated Forms And Templates: 116.1MED. 01 Clinical Study Report Tracking Log 3 28 Jun 13 117.1 MED. Archiving Study Files 3 09 Sep 13 Associated Forms And Templates: 117.1 MED. 01 Archiving Facility Log 3 09 Sep 13 117.1 MED. 02 Archiving Coordinator Log 2 09 Sep 13 117.1 MED. 03 Archiving Coordinator Backup Log 2 09 Sep 13 117.1 MED. 04 Archiving Coordinator Take Over 2 09 Sep 13 117.1 MED. 05 Post Study Checklist 3 09 Sep 13 117.1 MED. 06 Content of Archived Box 2 09 Sep 13 117.1 MED. 07 List of Archived Studies 2 09 Sep 13 117.1 MED. 08 Retrieve from Archives Request 2 09 Sep 13 117.1 MED. 09 Confirmation of Destruction 2 09 Sep 13 117.1 MED. 10 Inventory of Archiving Boxes 2 09 Sep 13 117.1 MED. 11 Inventory of Archiving Locking Seals 2 09 Sep 13 117.1 MED. 12 Content of Archiving File 2 09 Sep 13 117.3 MED Management of Electronic Correspondence 1 29 Mar 13 121.1 MED. Contracts with Investigators and Investigational Sites 4 01 Feb 10 Associated Forms And Templates: 121.1 MED. 01 Bilateral contract (investigator) 121.1 MED. 02 Bilateral contract (centre) 4 4 08 Aug 11 08 Aug 11 121.1 MED. 12Tripartite contract (investigator & centre) – MD 2 08 Aug 11 VBL Confidential Information Page 92 of 101 Version 2.2 02 DEC 2013 Portions of this exhibit have been omitted and filed separately with the SEC pursuant to a confidential treatment request and are indicated by [***]. 121.1 MED. 13 Bilateral contract (investigator-coordinator) – MD 2 08 Aug 11 122.1 MED. Confidentiality Agreements and Confidentiality Obligation 3 14 Mar 11 123.1 MED. Principles of drawing contracts and master service agreements 2 28 Mar 11 Associated Forms And Templates: 123.1 MED. 01 KCR Group Contract Template: Master Service Agreement 123.1 MED. 02 KCR Group Contract Template: Service Agreement for a clinical study conduct 2 1 28 Mar 11 20 Oct 08 124.1 MED. Fraud and Misconduct 3 11 Feb 13 125.1 MED. Purchases Within a Project 1 25 Jul 11 127.1 MED. Legislation in Clinical Trials 2 31 Jul 13 127.3 MED Regulatory Intelligence Associated Forms And Templates: 127.3 MED.01 Regulatory Intelligence Responsibilities 1 1 28 Dec 12 28 Dec 12 128.1 MED. Communication with Subcontractor Associated Forms And Templates: 128.1 MED. 01 Subcontractor Tracking Log 1 1 01 Sep 11 01 Sep 11 129.1 MED. Annual Progress Report to...
med. Investigator’s File 1 16 Sep 13 Associated Forms And Templates: 109.5 MED. 01 Investigator´s File Table of Content 1 16 Sep 13 109.5 MED. Electronic Study Folder and Shadow File 109.7 MED.01 Shadow File Coordinators Log 109.7 MED.02 Electronic Folder Names 109.7 MED.03 Example of Electronic Study Folder and Shadow File Structure 1 1 1 1 16 Sep 13 16 Sep 13 16 Sep 13 16 Sep 13 110.1 MED. Clinical Supplies 3 16 Sep 13 Associated Forms And Templates: 110.1 MED. 01 Temperature Log 3 16 Sep 13 110.1 MED. 02 Clinical Supply Shipment Management Log 3 16 Sep 13 110.1 MED. 03 Clinical Supply Accountability Form 3 16 Sep 13 110.1 MED. 04 Re-labelling Report 3 16 Sep 13 110.1 MED. 05 Investigational product RECALL form 3 16 Sep 13 110.1 MED. 06 Investigational product RETURN form 3 16 Sep 13 110.1 MED. 07 Clinical Supply Destruction Report 110.1 MED.08 Site Investigational Product Accountability Log 3 1 16 Sep 13 16 Sep 13 111.1 MED. Clinical Trial Materials 2 30 Sep 13 Associated Forms And Templates: 111.1 MED.01 Trial Supply Shipment Form 4 30 Sep 13 111.1 MED.02 Controlled Copy Distribution Log 3 30 Sep 13 111.1 MED.03 Frozen Samples storage log 3 30 Sep 13 111.1 MED.04 Investigator’s Brochure Acknowledgement of Receipt 2 30 Sep 13 VBL Confidential Information Page 1 of 64 Version 2.2 02 DEC 2013 Portions of this exhibit have been omitted and filed separately with the SEC pursuant to a confidential treatment request and are indicated by [***]. 112.1 MED. Serious Adverse Event Reporting 3 08 Mar 13 Associated Forms And Templates: 112.1 MED. 01 SAE Pregnancy Report Form 3 08 Mar 13 112.2 MED. Distribution of SUSAR reports 2 15 Sep 11 Associated Forms And Templates: 112.2 MED. 01 SUSAR Reports Tracking Log 2 15 Sep 11 112.5 MED. Safety Management Principles 1 16 Sep 2013
med. Virol, II, de La Maza & Peterson, eds. Cremer et al., (1982) J. Clin, Microbiol., 15:815-823. Veronese, F. M., et al., (1981), Photochem. Photobiol. 34:351. Veronese et al. (1982), Photochem. Photobiol. 36:25. Singh and Vadasz (1978) Photochem. Photobiol. 28:539-545. Musajo et al., Experentia, vol. XXI, pp. 22-24, "Photosensitizing Furocovmanhs-Interaction with DNA and Photoinactivation of DNA Containing Viruses". Primary Examiner--Thomas G. Wiseman Assistant Examiner--Robin Lyn Tieskin Attorney, Agent, or Firm--Zarley McKee, Thomte, Voorhees & Sease [57] ABSTRACT Biological compositions are decontaminated by treatment with furocoumarin derivatives and irradiation under particular conditions in which the proteins retain their original physiological activities and any pathogenic microorganisms and polynucleotide fragments thereof are rendered inactive. It has been found that reduction of the amount of dissolved oxygen in the treatment solution substantially inhibits denaturation of the proteins.
med. Christoph H. Gleiter Seite 1/1 AB Sitz der Gesellschaft: Tübingen Registergericht: Tübingen, HR8 2165 Vorsitzender des Aufsichtsrates: Prof. Dr. med. Claus D. Claussen QuickLinks
med. Trial Master File 1 16 Sep 13 Associated Forms And Templates: 109.2 MED. 01 Trial Maser File Table of Content 1 16 Sep 13 109.2 MED. 02 Trial Maser File and Shadow File Review Form 109.2 MED. 03 TMF Transfer Form 109 3 MED 04 Study Documentation Management Form 1 1 1 16 Sep 13 16 Sep 13 16 Sep 13
med. A. Münscher (Otorhinolaryngology, The liquidation right is the responsibility of the hospital) Surgical Clinics, Geriatric Clinic, Internal Medicine, Cardiology, Pneumology, Gastroenterology, Angiology PRI-MED-ACC GmbH Privatärztliche Abrechnung, Hochwaldallee 61, 16562 Bergfelde - Dr. med. H. Bühre (Geriatric Clinic) - Dr. med. R. Feil (Surgical Clinic) - Prof. Dr. med. C. Müller (Surgical Clinic) - Dr. med. B. Riefel (Surgical Clinic, The liquidation right is the responsibility of the hospital) - Prof. Dr. med. U. Vanhoefer (Internal Medicine) - Dr. Borlich (Inerventional Pneumology, The liquidation right is the responsibility of the hospital) - Prof. Dr. med. U. Schäfer (Cardiology, The liquidation right is the responsibility of the hospital) - Dr. med. I. Nowak (Angiology, The liquidation right is the responsibility of the hospital)
med. Dr.rer.nat Ernst-Gunter Afting ------------------------------------------- (print name) By: /s/ illegible --------------------------------------- Title: ------------------------------------ Address: ---------------------------------- ------------------------------------------- ------------------------------------------- [INVESTOR SIGNATURE PAGE TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT] SEQUENOM, INC. Registration Rights Agreement Investor Signature Page ----------------------- By executing this page in the space provided, the undersigned hereby agrees (i) that it is an "Investor" as defined in the Registration Rights Agreement dated as of December 21, 1998, by and among Sequenom, Inc. and the parties named therein, (ii) that it is a party to the Registration Rights Agreement for all purposes and (iii) that it is bound by all terms and conditions of the Registration Rights Agreement. EXECUTED this 21st day of December, 1998. Alpinvest International B.V. ------------------------------------ (print name) By: /s/ illegible -------------------------------- Title: ----------------------------- Address: Gooimeer 3, P.O. Box 5073 --------------------------- 1410 AB Naarden --------------------------- The Netherlands --------------------------- [INVESTOR SIGNATURE PAGE TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT] SEQUENOM, INC. Registration Rights Agreement Investor Signature Page ----------------------- By executing this page in the space provided, the undersigned hereby agrees (i) that it is an "Investor" as defined in the Registration Rights Agreement dated as of December 21, 1998, by and among Sequenom, Inc. and the parties named therein, (ii) that it is a party to the Registration Rights Agreement for all purposes and (iii) that it is bound by all terms and conditions of the Registration Rights Agreement. EXECUTED this 21st day of December, 1998. KREDIETBENK S.A. LUXEMBOURCEOIE AS NOMINEE FOR KB LUX VENTURE CAPITAL FUND (illegible) By: /s/ illegible ---------------------------------- Title: Manager ------------------------------ Address: 43 Boulevard Royal ----------------------------- L-2955 Luxembourg ----------------------------- ----------------------------- [INVESTOR SIGNATURE PAGE TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT] SEQUENOM, INC. Registration Rights Agreement Investor Signature Page ----------------------- By executing this page in the space provided, the undersigned hereby agrees (i) that it is an "Investor" as...